Innate Pharma (IPH.PA) Q1 2024 Earnings

21MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q1 2024
-0.41
-0.27
-0.14
0

Details

Expected EPS
-0.40978337156911
Actual EPS
-0.1219191204
Surprise EPS
0.29
Surprise Percent
+70.25%

Description

Innate Pharma (IPH.PA) has reported earnings of -0.1219191204 per share for Q1 2024.

0 Comments

Share your thoughts